Mexican-made COVID-19 vaccine could be ready this year
Mexico aims to have developed a vaccine against COVID-19 that could be granted approval for emergency use this year, an senior official said on ...
BookmarkMEXICO CITY: Mexico aims to have developed a vaccine against COVID-19 that could be granted approval for emergency use this year, an senior official said on Tuesday (Apr 13), an outcome that could wean it off unreliable foreign supplies for its slow vaccination program.
The head of the National Council of Science and Technology (Conacyt), Maria Elena Alvarez-Buylla, told a news conference that the vaccine under development could be granted approval in November or December of this year.AdvertisementAdvertisementClinical trials with volunteers could begin this month, according to Avimex, the veterinary pharmaceutical company that is leading the vaccine's development in Mexico.
If the trails are successful, the"Patria" vaccine could help Mexico and other developing nations that have struggled to secure supplies of foreign-made shots that rich countries have snapped up.Mexico has so far acquired 16.9 million vaccine doses for its population of 126 million, all from foreign companies including Pfizer-BioNTech, Sinovac, AstraZeneca, CanSino and Sputnik V, according to government data. headtopics.com
The costs to acquire Avimex's vaccine would be 800 per cent lower than imported foreign vaccines, the government said.AdvertisementAdvertisementMexico has reported 2,286,133 infections and 210,294 deaths from COVID-19, the seventh-highest death toll per head of population in the world, according to Johns Hopkins University.
The government says the real case numbers are likely to be significantly higher, and separate health ministry data suggests the actual death toll may be at least 60 per cent above the confirmed figure.GLOBAL EFFORTPatria is being developed with technology from the Icahn School of Medicine at Mount Sinai in New York and a HexaPro protein developed by the University of Texas at Austin.
AdvertisementThe company said it used existing technology from its veterinary influenza vaccine, which has been proven safe for humans, for an effective COVID-19 vaccine."After analysing the technological platforms at its disposal, Avimex determined that a recombinant Newcastle disease virus (rNDV) has the potential for success for the COVID-19 vaccine," the company said in a statement.
Other versions of the vaccine will enter clinical trials as injections in Brazil, Thailand and Vietnam. These have the same molecular makeup using the HexaPro construction in rNDV, and are developed by the US institutes and research partners in those countries. headtopics.com
Avimex's version, however, is the only one to be tested using an active virus, a company spokeswoman said. The Avimex version is also the only one being tested as an intranasal spray as well as an injection, she said.Mexico's foreign ministry and Conacyt contributed funding, Avimex said.Read more: CNA »
1.8 million people have received at least one dose of COVID-19 vaccine: Health minister
A total of 1.2 million people have completed the full vaccination regimen, says Mr Gan Kim Yong.
Risk from COVID-19 variants remains after first Pfizer COVID-19 vaccine, UK study findsLONDON :A single dose of Pfizer's coronavirus vaccine may not generate a sufficient immune response to protect against dominant new variants, ... 所以那些還沒有完成接種第二針疫苗的國家是不能對印度，巴基斯坦，尼泊爾，斯里蘭卡開放的。 3rd and 4th doses coming your way. Then 5th and 6th......... WHILE VIRYS MUTATES
Sweden registers 7,736 new COVID-19 cases, 19 deaths on ThursdaySweden, which has shunned lockdowns throughout the pandemic, registered 7,736 new COVID-19 cases on Thursday, health agency statistics showed.
7 more workers at Westlite Woodlands dorm test positive for Covid-19, bringing total to 19SINGAPORE — Seven more workers from the Westlite Woodlands dormitory have tested positive for Covid-19 after recovering from past infections, bringing the total number of cases at the dormitory to 19, the Ministry of Manpower clarified on Thursday (April 22). Must have returned India and back... It's normal. Vaccine working. Give it some time. Ensure that they spread more to do litmus test to the said vaccine.
Most COVID-19 business capacity limits to end in New York region on May 19New York, New Jersey and Connecticut will lift most of their coronavirus capacity restrictions on businesses, including retail stores, food ...
19 people investigated for breaching COVID-19 measures at Fusionopolis pubSINGAPORE: Nineteen people are being investigated for suspected breaches of COVID-19 safe distancing measures at a pub located at Fusionopolis in ...
19 people investigated for breaching Covid-19 measures at Fusionopolis pub